Heart Failure

On this page

Heart Failure - The Failing Pump

  • Heart failure (HF): a clinical syndrome in which the heart cannot provide adequate output for metabolic needs, or can do so only at elevated filling pressures.

    • HFrEF (HF with reduced ejection fraction): LVEF ≤40%
    • HFmrEF (HF with mildly reduced ejection fraction): LVEF 41-49%
    • HFpEF (HF with preserved ejection fraction): LVEF ≥50%
  • Clinical classifications:

    SystemStages summary
    NYHA functional classI: no limitation; II: slight limitation; III: marked limitation; IV: symptoms at rest
    ACC/AHA stagesA: at risk; B: pre-HF; C: symptomatic HF; D: advanced HF

⭐ The most common cause of right-sided heart failure is left-sided heart failure.

Heart Failure - Why It Breaks

Major etiologies

  • Ischemic heart disease / prior myocardial infarction: the most common cause of HFrEF; loss of viable myocardium and adverse ventricular remodeling impair systolic function.
  • Hypertension: chronic pressure overload causes left ventricular hypertrophy and diastolic dysfunction; it may progress to systolic dysfunction.
  • Valvular heart disease: aortic stenosis and chronic hypertension produce pressure overload, whereas mitral or aortic regurgitation produces volume overload.
  • Cardiomyopathies and myocarditis: dilated, hypertrophic, restrictive, infiltrative (e.g., amyloidosis), inflammatory, genetic, peripartum, alcohol-related, and cardiotoxic drug-related disease.
  • Arrhythmias: persistent tachyarrhythmias can cause tachycardia-induced cardiomyopathy; severe bradyarrhythmias may also precipitate HF.
  • Other causes: congenital heart disease, endocrine or metabolic disease (e.g., thyroid disease), pericardial disease, and right-sided pressure overload from pulmonary hypertension or chronic lung disease.

High-output heart failure

Cardiac output may be elevated but still inadequate for excessive tissue demand. Important causes include severe anemia, thyrotoxicosis, large arteriovenous fistula, beriberi, and Paget disease.

Core pathophysiology

  1. Myocardial injury or abnormal pressure/volume loading reduces effective cardiac performance.
  2. Reduced renal perfusion activates the sympathetic nervous system and renin-angiotensin-aldosterone system, causing vasoconstriction and sodium-water retention.
  3. Increased preload and afterload initially support perfusion but later worsen congestion and myocardial workload.
  4. Chronic neurohormonal activation promotes ventricular hypertrophy, dilation, fibrosis, and adverse remodeling, creating a self-perpetuating cycle of HF.

⭐ Distinguish the underlying cause of HF from a precipitating factor for decompensation. Common precipitants include acute coronary syndrome, uncontrolled hypertension, arrhythmia, infection, medication or dietary nonadherence, renal dysfunction, and pulmonary embolism.

Heart Failure - Spotting Trouble

  • Symptoms: Dyspnea (DOE, orthopnea, PND), fatigue, edema, cough (frothy).

  • Signs: Tachycardia, S3/S4, ↑JVP, edema, creps, hepatomegaly.

  • 📌 Mnemonics:

    • Left HF (DOABLE): Dyspnea, Orthopnea, Awakening, Basal creps, Lung sounds-wheeze, Expectoration-frothy.
    • Right HF (CHAPS): Cor pulmonale, Hepatomegaly, Ascites, Peripheral edema, Splenomegaly.
  • Diagnostic Tools:

    • ECG: LVH, prior MI, arrhythmias.
    • CXR: Cardiomegaly, pulm. congestion (Kerley B), effusion.
    • Echo (key): EF, wall motion, diastolic fx, valves.
    • Biomarkers: BNP > 100, NT-proBNP > 300 pg/mL (↑ if renal issues/elderly).
  • Framingham criteria aid CHF diagnosis.

Loading diagram…

⭐ S3 gallop: highly specific for HF, especially with dyspnea.

Heart Failure - Mending Hearts

  • Nonpharmacologic care: regular activity or cardiac rehabilitation when stable, vaccination, daily weight monitoring, smoking cessation, and avoidance of excess sodium. Consider fluid restriction (usually 1.5-2 L/day) mainly for severe congestion or hyponatremia rather than routinely for every patient.
  • Four foundational therapies for HFrEF-initiate early and titrate as tolerated:
    • ARNI (sacubitril/valsartan preferred when appropriate), or an ACE inhibitor/ARB if ARNI cannot be used
    • An evidence-based beta-blocker: carvedilol, metoprolol succinate, or bisoprolol
    • MRA: spironolactone or eplerenone; monitor potassium and renal function
    • SGLT2 inhibitor: dapagliflozin or empagliflozin, irrespective of diabetes status
  • Loop diuretics relieve congestion but do not replace mortality-reducing foundational therapy.
  • HFpEF: use an SGLT2 inhibitor when appropriate, treat congestion with diuretics, and manage hypertension, atrial fibrillation, obesity, diabetes, chronic kidney disease, ischemia, and sleep apnea.
  • Devices after optimized therapy:
    • ICD for eligible patients at risk of sudden cardiac death, considering LVEF, symptoms, etiology, expected survival, and timing after myocardial infarction or revascularization.
    • CRT has strongest support in symptomatic patients in sinus rhythm with LVEF ≤35%, left bundle branch block, and QRS ≥150 ms despite optimized therapy; selected patients with other QRS patterns or durations may also qualify.

⭐ In eligible patients with chronic symptomatic HFrEF, sacubitril/valsartan reduces cardiovascular death and HF hospitalization compared with enalapril.

Loading diagram…

Heart Failure - Code Blue Crisis

  • Definition: acute onset or worsening of HF signs and symptoms requiring urgent evaluation and treatment.
  • Common precipitants: acute coronary syndrome, arrhythmia (e.g., atrial fibrillation), infection, uncontrolled hypertension, pulmonary embolism, renal dysfunction, and medication or dietary nonadherence.
  • Immediate assessment: airway and work of breathing, oxygen saturation, blood pressure, perfusion, congestion, ECG, renal function/electrolytes, troponin, and the precipitating cause.
  • Stevenson profiles and general treatment approach:
    • Warm and wet: IV loop diuretic; add a vasodilator when blood pressure is adequate, especially in hypertensive pulmonary edema.
    • Cold and wet: IV loop diuretic with close hemodynamic assessment; use an inotrope only for persistent hypoperfusion despite adequate filling, and a vasopressor for cardiogenic shock.
    • Cold and dry: if true hypovolemia is suspected, give a cautious fluid challenge; consider an inotrope only if hypoperfusion persists.
    • Warm and dry: optimize chronic guideline-directed therapy and address the precipitating factor.
  • Give supplemental oxygen only for hypoxemia; use noninvasive ventilation for significant respiratory distress when appropriate.
  • In acute pulmonary edema, prioritize an upright position, ventilatory support as needed, nitrates when blood pressure permits, and IV loop diuretics when congestion is present. Routine morphine is not recommended because it may cause respiratory depression and hypotension.

⭐ The cold and wet profile has the worst prognosis because both congestion and hypoperfusion are present; escalation should be guided by blood pressure, perfusion, and shock status.

High‑Yield Points - ⚡ Biggest Takeaways

  • Ischemic heart disease is the most common cause of HFrEF.
  • NYHA functional class grades symptom-related limitation; ACC/AHA stages describe disease progression.
  • BNP/NT-proBNP support diagnosis and prognosis, but values must be interpreted in clinical context.
  • The four foundational therapies for HFrEF are an ARNI (or ACE inhibitor/ARB when ARNI is unsuitable), evidence-based beta-blocker, MRA, and SGLT2 inhibitor.
  • Sacubitril/valsartan reduces cardiovascular death and HF hospitalization compared with enalapril in eligible patients with chronic symptomatic HFrEF.
  • HFpEF management includes an SGLT2 inhibitor when appropriate, diuretics for congestion, and treatment of comorbidities such as hypertension, atrial fibrillation, obesity, diabetes, and chronic kidney disease.
  • In acute decompensated HF, assess congestion, perfusion, blood pressure, oxygenation, and the precipitating cause; routine morphine is not recommended.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Heart Failure

  1. 1. Which is NOT a typical chest-radiographic finding in left-sided heart failure with pulmonary venous congestion?

    • A. Cardiac enlargement
    • B. Kerley B lines
    • C. Kerley A Lines
    • D. Pulmonary oligemia
    Show answer

    Answer: D. Pulmonary oligemia

    Pulmonary oligemia is the exception because pulmonary venous congestion usually increases rather than reduces pulmonary vascular markings. Kerley A Lines are long interstitial opacities associated with oedema of deep pulmonary lymphatic channels and connective-tissue septa. Cardiac enlargement commonly accompanies chronic heart failure, although it is not universal. Kerley B lines represent oedematous peripheral interlobular septa and support interstitial pulmonary oedema. Reference: Harrison’s Principles of Internal Medicine, 21st edition, chapter 'Heart Failure: Pathophysiology and Diagnosis', chest-radiography section.

  2. 2. Nicotinic acid is useful in all types of hyperlipoproteinemias, EXCEPT:

    • A. Type-IV
    • B. Type-I
    • C. Type-II
    • D. Type-III
    Show answer

    Answer: B. Type-I

    Type-I - Type-I hyperlipoproteinemia results from lipoprotein lipase or ApoC-II deficiency, causing massive accumulation of dietary chylomicrons in plasma. - Niacin primarily reduces hepatic VLDL production and does not significantly improve chylomicron clearance; therefore, it is ineffective in Type-I disease. Type-IV - Type-IV hyperlipoproteinemia is characterized by elevated VLDL and triglycerides, which are reduced by niacin through inhibition of adipose hormone-sensitive lipase and hepatic VLDL production. - Because niacin lowers VLDL secretion, it is useful in Type-IV disease rather than being the exception sought in the question. Type-II - In Type-II hyperlipoproteinemia, niacin can reduce LDL by decreasing VLDL synthesis and its subsequent conversion to LDL. - This mechanism makes niacin useful in Type-IIa and Type-IIb patterns, so Type-II is not the exception. Type-III - Type-III dysbetalipoproteinemia involves accumulation of remnant particles, including IDL, and niacin can reduce their precursor VLDL. - By decreasing VLDL production, niacin may help lower remnant particles in Type-III disease; therefore, this option does not fit the exception.

  3. 3. Which antiarrhythmic drug is best avoided in a patient with pre-existing interstitial lung disease because of its characteristic pulmonary toxicity?

    • A. Amiodarone
    • B. Sotalol
    • C. Lignocaine
    • D. Quinidine
    Show answer

    Answer: A. Amiodarone

    Amiodarone - Amiodarone can cause interstitial pneumonitis and pulmonary fibrosis; pre-existing interstitial lung disease warrants particular caution, and an alternative is preferred when suitable. - Its prolonged half-life promotes drug accumulation and persistent adverse effects, so pulmonary toxicity may remain clinically important even after treatment is stopped. Lignocaine - Lignocaine is a Class Ib antiarrhythmic used mainly for acute ventricular arrhythmias, rather than a drug characteristically associated with pulmonary toxicity. - Its important adverse effects are predominantly neurological and cardiovascular, including dizziness, seizures at high doses, hypotension, and bradycardia, not worsening interstitial lung disease. Quinidine - Quinidine is a Class Ia antiarrhythmic more characteristically associated with gastrointestinal upset, cinchonism, and cardiac rhythm disturbances. - Although quinidine can rarely cause hypersensitivity pneumonitis, this is not the primary pulmonary concern or typical contraindication in interstitial lung disease compared with amiodarone. Sotalol - Sotalol has beta-blocking and Class III effects, with its major safety concern being QT prolongation and torsades de pointes. - Although sotalol can produce cardiac and minor non-cardiac adverse effects, it is not specifically associated with causing or worsening interstitial lung disease.

  4. 4. In the adult general population, what is the most common cause of left ventricular hypertrophy?

    • A. Obstructive HCM
    • B. Aortic Regurgitation
    • C. Hypertension
    • D. Aortic Stenosis
    Show answer

    Answer: C. Hypertension

    Hypertension - Systemic hypertension increases left ventricular afterload, requiring higher pressure generation and producing compensatory concentric hypertrophy. - Because hypertension is highly prevalent and causes chronic pressure overload, it is the most common cause of LVH in the general population. Obstructive HCM - HOCM is a primary genetic myocardial disorder causing typically asymmetric septal hypertrophy, rather than the common secondary LV pressure-overload response. - Its relative rarity makes it much less common as a population cause of LVH than systemic hypertension. Aortic Stenosis - Aortic stenosis creates chronic pressure overload, producing concentric LVH as the ventricle generates higher pressure across the narrowed valve. - Although it is a classic cause of LVH, its epidemiological frequency is lower than that of systemic hypertension. Aortic Regurgitation - Aortic regurgitation causes chronic volume overload, leading predominantly to eccentric hypertrophy with ventricular dilatation and sarcomeres added in series. - Although it can enlarge and remodel the left ventricle, it is not the most common cause of generalized LVH.

  5. 5. A 30-year-old hypertension patient presents with daily headaches. The CXR given below shows which of the following?

    • A. Postductal coarctation
    • B. Dissection of the aorta
    • C. Preductal coarctation
    • D. Takayasu arteritis
    Show answer

    Answer: A. Postductal coarctation

    Postductal coarctation - Rib notching indicates enlarged collateral vessels developing around an aortic narrowing, classically seen with postductal coarctation. - A narrowing distal to the ductus arteriosus produces upper-extremity hypertension, which explains the patient’s headaches and supports this diagnosis in an adult. Dissection of the aorta - Dissection of the aorta involves an acute tear within the aortic wall and typically presents with sudden, severe chest or back pain. - The expected radiographic clue is often a widened mediastinum, rather than the chronic collateral-vessel rib notching described here. Preductal coarctation - Preductal coarctation lies proximal to the ductus arteriosus and commonly presents during infancy with heart failure. - An adult with hypertension and rib notching is more consistent with postductal disease, which allows time for collateral circulation to develop. Takayasu arteritis - Takayasu arteritis is a granulomatous vasculitis affecting the aorta and major branches, causing arterial wall thickening, stenoses, or occlusions. - Although it may cause hypertension, rib notching is not its characteristic chest-radiograph finding and does not explain this pattern as well as coarctation.

  6. 6. A 36-year-old man presents with shock, raised JVP and clear lung fields. His ECG is shown. What is the most likely cause of shock?

    • A. Ventricular septal perforation
    • B. Cardiac rupture
    • C. Papillary muscle rupture
    • D. Right ventricular infarction
    Show answer

    Answer: D. Right ventricular infarction

    Right ventricular infarction - ST elevation in II, III, and aVF indicates an inferior infarction, while elevation in V4R specifically supports right ventricular involvement. - A failing right ventricle causes preload-dependent cardiogenic shock, characterized by hypotension, raised JVP, and clear lung fields because left-sided filling and pulmonary congestion are reduced. Ventricular septal perforation - Ventricular septal perforation causes an acute left-to-right ventricular shunt, which can produce shock through volume overload and pulmonary congestion. - It usually occurs several days after myocardial infarction and is associated with a harsh holosystolic murmur, the ECG evidence specifically supports right ventricular involvement. Cardiac rupture - Free-wall cardiac rupture causes hemopericardium and cardiac tamponade, producing shock through impaired cardiac filling. - It generally occurs later after infarction; the combination of raised JVP, hypotension, clear lungs, and V4R elevation more specifically indicates right ventricular involvement. Papillary muscle rupture - Papillary muscle rupture causes acute mitral regurgitation, which typically produces pulmonary edema and often a new systolic murmur. - The clear lung fields and right-sided ST elevation favour right ventricular infarction over acute severe mitral regurgitation.

  7. 7. In an infant with congestive heart failure, which is the most reliable clinical sign of systemic venous congestion?

    • A. Pedal edema
    • B. Raised JVP
    • C. Basal crackles
    • D. Hepatomegaly
    Show answer

    Answer: D. Hepatomegaly

    Hepatomegaly - Hepatomegaly is a crucial sign of pediatric CHF because hepatic venous congestion produces enlargement of the compressible liver. - The liver can accommodate substantial increases in blood volume, allowing hepatomegaly to become apparent before other signs of systemic venous congestion. Raised JVP - Raised JVP can indicate systemic venous congestion in older children with CHF, but it is difficult to assess reliably in infants and young children because of their short necks and limited cooperation. - Compared with hepatomegaly, raised JVP is less sensitive and less practical as a diagnostic sign across pediatric age groups, particularly in younger children. Basal crackles - Basal crackles indicate pulmonary edema from pulmonary venous congestion and are therefore more suggestive of left-sided heart failure. - Although crepitations may occur in CHF, hepatomegaly is a more consistent and often earlier finding across different forms of pediatric heart failure. Pedal edema - Pedal edema is less common in pediatric CHF, especially in infants and toddlers, than in adults with systemic venous congestion. - Shorter hydrostatic columns and prolonged supine positioning reduce dependent edema, making pedal swelling less prominent than hepatomegaly.

  8. 8. A 1-year-old boy treated with digoxin for ventricular septal defect–associated heart failure develops poor feeding after a dosing error. Which arrhythmia is shown on the ECG?

    • A. Atrial fibrillation
    • B. Ventricular bigeminy
    • C. Complete atrioventricular block
    • D. Ventricular tachycardia
    Show answer

    Answer: B. Ventricular bigeminy

    Ventricular bigeminy is shown because each sinus beat is followed by a premature broad ventricular complex. Atrial fibrillation would show an irregularly irregular rhythm without consistent sinus P waves. Complete atrioventricular block would show independent atrial and ventricular activity. Ventricular tachycardia would show a sustained sequence of ventricular complexes rather than alternating sinus beats and isolated ventricular ectopics.

  9. 9. A 58-year-old man with diabetes mellitus had a myocardial infarction two months ago and is not taking lipid-lowering therapy. His triglycerides are 234 mg/dL, LDL 124 mg/dL and HDL 32 mg/dL. Which lipid-lowering regimen is most appropriate?

    • A. Rosuvastatin 10 mg monotherapy
    • B. Rosuvastatin 10 mg/fenofibrate 145 mg
    • C. Fenofibrate 145 mg monotherapy
    • D. Atorvastatin 80 mg monotherapy
    Show answer

    Answer: D. Atorvastatin 80 mg monotherapy

    Atorvastatin 80 mg monotherapy - Atorvastatin 80 mg is a high-intensity statin that lowers LDL by at least 50%, appropriate for a patient with recent myocardial infarction and established coronary artery disease. - High-intensity statin therapy supports secondary prevention through substantial LDL reduction and plaque stabilization, regardless of the baseline LDL concentration. Rosuvastatin 10 mg monotherapy - Rosuvastatin 10 mg provides only moderate-intensity LDL reduction of approximately 30–49%, which is inadequate after a recent myocardial infarction. - This patient requires high-intensity statin therapy for secondary prevention, with greater LDL lowering and plaque-stabilizing benefit than this dose provides. Rosuvastatin 10 mg/fenofibrate 145 mg - Although the patient has elevated triglycerides, routine fenofibrate combination therapy is not initial treatment when triglycerides are 234 mg/dL and ASCVD is established. - Combining a fibrate with a statin increases myopathy and rhabdomyolysis risk without established additional cardiovascular benefit for this degree of hypertriglyceridemia. Fenofibrate 145 mg monotherapy - Fenofibrate monotherapy does not provide the preferred secondary prevention strategy after myocardial infarction, because statins have stronger evidence for reducing recurrent cardiovascular events. - Fibrates are generally prioritized for severe hypertriglyceridemia, particularly levels above 500 mg/dL, whereas this patient’s triglycerides are 234 mg/dL.

  10. 10. Which medication is commonly used in heart failure that also has aldosterone antagonistic properties?

    • A. Furosemide
    • B. Spironolactone
    • C. Sacubitril/Valsartan
    • D. Carvedilol
    Show answer

    Answer: B. Spironolactone

    Spironolactone - Spironolactone is a potassium-sparing diuretic that competitively antagonizes aldosterone receptors in the renal collecting ducts, increasing sodium and water excretion while retaining potassium. - In heart failure, aldosterone blockade helps reduce fluid overload and limits adverse cardiac remodeling, making spironolactone the appropriate choice. Furosemide - Furosemide treats congestion in heart failure by inhibiting the Na⁺–K⁺–2Cl⁻ cotransporter in the thick ascending limb; it does not antagonize mineralocorticoid receptors. Sacubitril/Valsartan - Sacubitril/valsartan is an ARNI combining neprilysin inhibition with angiotensin-receptor blockade, making it effective in heart failure but not a direct aldosterone-receptor antagonist. - Although it modulates the RAAS, its mechanism differs from the competitive aldosterone blockade provided by spironolactone. Carvedilol - Carvedilol is a beta-blocker with additional alpha-1-blocking activity, used in heart failure to reduce heart rate, blood pressure, and myocardial oxygen demand. - It does not possess significant aldosterone-antagonistic properties, so it cannot provide the direct mineralocorticoid-receptor blockade described in the question.

Flashcards: Heart Failure

  1. 1. _____ heart failure may present with pulmonary _____ due to increased pulmonary venous pressure

    Show answer

    Left · edema

  2. 2. Does digoxin reduce mortality in patients with chronic heart failure?_____

    Show answer

    No

  3. 3. The most common cause of isolated right-sided heart failure is .

    Show answer

    parenchymal lung disease

  4. 4. _____ heart failure may cause _____ distension due to increased systemic venous pressure

    Show answer

    Right · jugular venous

  5. 5. Myocardial infarction induced acute left ventricular failure can result in rapid onset _____ and _____

    Show answer

    pulmonary venous hypertension · acute pulmonary edema

  6. 6. Falsely _____ BNP values can be seen in _____ patients and during _____.

    Show answer

    low · obese · flash pulmonary edema

  7. 7. is the most common underlying etiology of left-sided diastolic heart failure.

    Show answer

    Hypertension

  8. 8. In patients with hypertension and what comorbidity should ACE inhibitors / ARBs become first line? _____

    Show answer

    Hypertension with Diabetes Mellitus

  9. 9. Electric cardioversion is _____effective in the management of Multifocal atrial tachycardia

    Show answer

    in

  10. 10. What pathology is indicated on the ECG below? _____

    Show answer

    1st degree AV block

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF